Mays Vickie M, Jones Audrey L, Delany-Brumsey Ayesha, Coles Courtney, Cochran Susan D
*Department of Health Policy and Management, UCLA Fielding School of Public Health †UCLA Center for Bridging Research, Innovation, Training and Education for Minority Health Disparities Solutions, Los Angeles, CA ‡Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA §Vera Institute of Justice, New York, NY.
Med Care. 2017 Feb;55(2):173-181. doi: 10.1097/MLR.0000000000000638.
Experiences of discrimination in health care settings may contribute to disparities in mental health outcomes for blacks and Latinos. We investigate whether perceived discrimination in mental health/substance abuse visits contributes to participants' ratings of treatment helpfulness and stopped treatment.
We used data from 3 waves of the California Quality of Life Survey, a statewide population-based telephone survey assessing mental health/substance disorders and their treatment. In a sample of 1099 adults (age 18-72) who indicated prior year mental health/substance abuse visits, we examined: experiences of discrimination that occurred during health care and mental health/substance abuse visits, ratings of treatment helpfulness, and reports of stopping treatment early.
Fifteen percent of California adults reported discrimination during a health care visit and 4% specifically during mental health/substance abuse visits. Latinos, the uninsured, and those with past year mental disorders were twice as likely as others to report health care discrimination [adjusted odds ratio (AORs)=2.08, 2.77, and 2.51]. Uninsured patients were 7 times more likely to report discrimination in mental health/substance abuse visits (AOR=7.27, P<0.01). The most commonly reported reasons for health care discrimination were race/ethnicity for blacks (52%) and Latinos (31%), and insurance status for whites (40%). Experiences of discrimination in mental health/substance abuse visits were associated with less helpful treatment ratings for Latinos (AOR=0.09, P<0.05) and whites (AOR=0.25, P<0.01), and early treatment termination for blacks (AOR=13.38, P<0.05).
Experiences of discrimination are associated with negative mental health/substance abuse treatment experiences and stopped treatment, and could be a factor in mental health outcomes.
在医疗环境中遭受歧视的经历可能导致黑人和拉丁裔在心理健康结果方面存在差异。我们调查了在心理健康/药物滥用就诊中感受到的歧视是否会影响参与者对治疗帮助程度的评级以及是否会导致治疗中断。
我们使用了来自三轮加利福尼亚生活质量调查的数据,这是一项基于全州人口的电话调查,评估心理健康/药物障碍及其治疗情况。在1099名表示上一年有心理健康/药物滥用就诊经历的成年人(年龄在18 - 72岁之间)样本中,我们研究了:在医疗保健和心理健康/药物滥用就诊期间发生的歧视经历、对治疗帮助程度的评级以及提前终止治疗的报告。
15%的加利福尼亚成年人报告在医疗保健就诊期间受到歧视,4%的人特别指出在心理健康/药物滥用就诊期间受到歧视。拉丁裔、未参保者以及过去一年患有精神障碍的人报告医疗保健歧视的可能性是其他人的两倍[调整后的优势比(AORs)分别为2.08、2.77和2.51]。未参保患者在心理健康/药物滥用就诊中报告受到歧视的可能性高出7倍(AOR = 7.27,P < 0.01)。医疗保健歧视最常被报告的原因,对于黑人(52%)和拉丁裔(31%)是种族/族裔,对于白人(40%)是保险状况。在心理健康/药物滥用就诊中遭受歧视的经历与拉丁裔(AOR = 0.09,P < 0.05)和白人(AOR = 0.25,P < 0.01)对治疗帮助程度较低的评级相关,与黑人提前终止治疗(AOR = 13.38,P < 0.05)相关。
歧视经历与负面的心理健康/药物滥用治疗经历以及治疗中断相关,并且可能是心理健康结果的一个影响因素。